Drug discovery

Research Field Cancer

No Biomarker, No Trial?

| James Ritchie, Sidath Katugampola, Paul Jones

The vast majority of experimental cancer drugs fail during the later stages of clinical development
Research Field Public health

Stimulating Regulatory Science

| Jan Johannessen, Ameeta Parekh

We need better tools for assessing new medicines – and to develop them, we must work together.
Research Field Metabolism & Diabetes

A Single-Edged Sword for Diabetes?

| James Strachan

Autocrine-based screening has identified a more selective anti-diabetic drug candidate
Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register

October Issue of The Translational Scientist